Kisspeptin-10 for Menopause: What the Evidence Shows
What human and animal studies show about Kisspeptin-10 for menopause, how strong that evidence is, and what is still unproven.
- Strongest evidence
- None graded
- no study with an outcome for menopause (PubMed search, 11 Oct 2026)
- Human studies
- 3
- PubMed records, our ledger
- Animal studies
- 1
- PubMed records, our ledger
Evidence for menopause
None of the study abstracts we summarised for Kisspeptin-10 reported an outcome for menopause (PubMed search, 11 Oct 2026). Claims that it helps with menopause are unproven.
PubMed records for Kisspeptin-10 and menopause: 3 human, 1 animal (search counts, not studies we reviewed).
How strong is it?
A human randomized trial outweighs any number of animal studies. Animal and cell results show a mechanism worth testing, not that it works in people.
What menopause and perimenopause are
MedlinePlus defines menopause as the point 12 months after the last period, with the lead-up called the menopausal transition or perimenopause.[10]
MedlinePlus lists hot flashes, night sweats, mood changes, vaginal dryness and painful sex as symptoms that lower hormone levels can cause in menopause.[11]
What kisspeptin research exists in women
A PubMed search for kisspeptin-10 plus menopause terms found 3 human-filtered papers and 1 animal paper, none a randomized trial. None tests kisspeptin in menopausal women.
Calculated from pubmed query ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]) AND (menopaus*[tiab] OR postmenopaus*[tiab] OR perimenopaus*[tiab] OR climacteric[tiab] OR "hot flashes"[tiab] OR "hot flushes"[tiab] OR "vasomotor symptoms"[tiab]); date 2026-10-02; human filter count 3; human only count 3; animal filter count 1; randomized filter count 0. Formula: counts as recorded in the goals.json ledger (PubMed [tiab] query with the human, animal and RCT filters shown)
In premenopausal women, the effect of kisspeptin-54 was greatest in the preovulatory phase and least in the follicular phase of the cycle.[12]
In women with hypothalamic amenorrhea, responses to twice-daily kisspeptin-54 were significantly reduced by the 14th injection day.[13]
A kisspeptin receptor agonist, MVT-602, was tested in premenopausal women. Ovulation occurred within 5 days in 100% at the 3 μg dose and 60% on placebo.[14]
Kisspeptin studies in women that are not menopause outcomes
An IVF study of kisspeptin-54 for egg maturation reported pregnancy rates. That is a fertility outcome in women having IVF, not a menopause outcome.[15]
A randomized trial in women with hypoactive sexual desire disorder found that kisspeptin modulated sexual and facial attraction brain processing. That is not a menopause outcome.[16]
Other peptides people research for menopause
All peptides for menopause, comparedCommon questions
Does Kisspeptin-10 help with menopause?
None of the studies we summarised for Kisspeptin-10 (PubMed search, 11 Oct 2026) measured an outcome for menopause. Treat claims that it helps with menopause as unproven.
Is Kisspeptin-10 approved for menopause?
No. Kisspeptin-10 is not FDA approved for any use, including menopause.
What is the best peptide for menopause?
There is no single answer. Our menopause overview compares each candidate by evidence grade and legal status rather than by popularity.
Can kisspeptin help with menopause symptoms?
We found no study of kisspeptin in menopausal women, so there are no results on symptoms.[10]
Does kisspeptin work for perimenopause?
The kisspeptin studies in women cited here were done in premenopausal or amenorrheic women, and the effect varied with cycle phase.[12]
Does the body get used to kisspeptin?
In women with amenorrhea, hormone responses were significantly reduced by the 14th day of twice-daily injections.[13]
More on Kisspeptin-10
Sources
- 1PubMed search: ("kisspeptin-10"[tiab] OR "kisspeptin 10"[tiab]) AND humans[mh] (110 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 2PubMed search: (kisspeptin[tiab]) AND humans[mh] AND (randomized controlled trial[pt] OR clinical trial[pt]) (54 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 3PubMed search: kisspeptin[tiab] AND (half-life[tiab] OR pharmacokinetic*[tiab]) AND humans[mh] (13 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 4PubMed search: kisspeptin[tiab] AND humans[mh] AND (men[tiab] OR male[tiab]) AND (testosterone[tiab] OR hypogonadism[tiab]) (90 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 5PubMed search: kisspeptin[tiab] AND (menopaus*[tiab] OR postmenopaus*[tiab]) (89 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 6PubMed search: kisspeptin[tiab] AND (liver[tiab] OR NAFLD[tiab] OR hepatic[tiab]) (68 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 2 Oct 2026
- 7PubMed search: ("kisspeptin-10"[tiab] OR "kisspeptin-54"[tiab] OR kisspeptin[tiab]) AND humans[mh] AND (adverse[tiab] OR "side effect*"[tiab] OR safety[tiab] OR tolerab*[tiab] OR toxicity[tiab] OR "case report"[pt]) (75 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 8PubMed search: (kisspeptin[tiab]) AND (nausea[tiab] OR flush*[tiab] OR "injection site"[tiab] OR headache[tiab] OR "ovarian hyperstimulation"[tiab] OR tachyphylaxis[tiab] OR desensiti*[tiab]) AND humans[mh] (60 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 9PubMed search: (kisspeptin[tiab] OR "kisspeptin-54"[tiab] OR "kisspeptin-10"[tiab]) AND ("clinical trial"[pt] OR "randomized controlled trial"[pt]) AND (women[tiab] OR men[tiab]) AND (adverse[tiab] OR tolerat*[tiab] OR "side effects"[tiab]) (5 results)PubMed · 2026pubmed.ncbi.nlm.nih.govAccessed 11 Oct 2026
- 10Official web pageOfficial web page · web page
- 11medlineplus.gov pagemedlineplus.gov · web pagemedlineplus.gov
- 12Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle in women.The Journal of clinical endocrinology and metabolism · 2007PMID 17635940Accessed 2 Oct 2026
- 13Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea, but chronic administration causes tachyphylaxis.The Journal of clinical endocrinology and metabolism · 2009PMID 19820030Accessed 2 Oct 2026
- 14Endocrine profile of the kisspeptin receptor agonist MVT-602 in healthy premenopausal women with and without ovarian stimulation: results from 2 randomized, placebo-controlled clinical tricals.Fertility and sterility · 2024PMID 37925096Accessed 2 Oct 2026
- 15Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization.The Journal of clinical investigation · 2014PMID 25036713Accessed 2 Oct 2026
- 16Effects of Kisspeptin Administration in Women With Hypoactive Sexual Desire Disorder: A Randomized Clinical Trial.JAMA network open · 2022PMID 36287566Accessed 2 Oct 2026
Found an error? Report a correction.